MHRA has approved deuruxolitinib, marketed as Leqselvi, for adults with severe alopecia areata, adding a new prescription treatment option...
Read MoreKatalyze Data and SAS have developed DementAI, a UK-built artificial intelligence system designed to help identify Alzheimer’s disease risk...
Read MoreMHRA has approved imlunestrant tosylate (Inluriyo) for a defined group of adults with ER-positive, HER2-negative locally advanced or metastatic...
Read MoreAlzeCure Pharma has secured EU orphan drug status for ACD440 in erythromelalgia, building on an earlier US FDA orphan...
Read MoreBayer has officially begun a Phase 1 clinical trial for BAY3498264, an investigational oral selective SOS1 inhibitor designed to...
Read MoreEverest Medicines has announced groundbreaking results from its Phase 1b/2a clinical trial of EVER001, a novel Bruton’s tyrosine kinase...
Read More